Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma.Published in:Cancer & Metabolism, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40170-020-0209-8By:Ren, L.;Ruiz-Rodado, V.;Dowdy, T.;Huang, S.;Issaq, S. H.;Beck, J.;Wang, H.;Tran Hoang, C.;Lita, A.;Larion, M.;LeBlanc, A. K.Publication type:Article